Intensify early with insulin: study

Insulin should be added sooner rather than later in patients with type 2 diabetes who are poorly controlled on a GLP-1 receptor agonist, say Australian researchers.

But switching to insulin completely will do more harm than good for poorly controlled patients, they add.

Their study allocated nearly 40,000 patients to addition of insulin within six months of starting a GLP-1 agonist and just over 4,000